International Stem Cell Corporation (ISCO)
OTCMKTS
· Delayed Price · Currency is USD
0.176
+0.036 (25.79%)
Mar 9, 2026, 3:59 PM EST
International Stem Cell Revenue
International Stem Cell had revenue of $2.37M in the quarter ending September 30, 2025, with 8.72% growth. This brings the company's revenue in the last twelve months to $9.39M, up 10.12% year-over-year. In the year 2024, International Stem Cell had annual revenue of $9.09M with 16.64% growth.
Revenue (ttm)
9.39M
Revenue Growth
+10.12%
P/S Ratio
0.12
Revenue / Employee
293.47K
Employees
32
Market Cap
1.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.09M | 1.30M | 16.64% |
| Dec 31, 2023 | 7.79M | -391.00K | -4.78% |
| Dec 31, 2022 | 8.18M | 1.00M | 13.99% |
| Dec 31, 2021 | 7.18M | 48.00K | 0.67% |
| Dec 31, 2020 | 7.13M | -2.34M | -24.75% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evofem Biosciences | 17.73M |
| Halberd | 6.94K |
| Eastgate Biotech | 137.64K |
| Emmaus Life Sciences | 11.89M |
| Entia Biosciences | 265.47K |
| EV Biologics | 9.47M |
International Stem Cell News
- 1 year ago - International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results - Accesswire
- 2 years ago - Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting. - Business Wire
- 4 years ago - International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022 - Accesswire